Topera’s mapping systems help diagnose complex arrhythmias and allows physicians to develop individual treatment plans for patients, according to the news release.
The latest generation of mapping systems to receive FDA 510(k) clearance features almost instant intra-procedural mapping and re-mapping capabilities. The new mapping system also uses color imaging to help identify an electrophysiological process that sustains atrial fibrillation, according to the release.
More Articles on Medical Devices:
Refurbished Medical Device Market to Reach $8B by 2017
FDA Clears Smiths Medical to Market Patient-Controlled Pain Pump
FDA Approves Gore Medical’s Viabhan Endoprosthesis Devices Use Expansion
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
